March 29, 2016
AVEO Pharmaceuticals, Inc.
Offering Fraud
SANCTION AMOUNT: $4,000,000
Defendants: AVEO Pharmaceuticals, Inc.
Sanction in settlement of allegations that company raised $53 million in a public stock offering while failing to disclose that the FDA had recommended an additional clinical trial for its flagship developmental drug to treat kidney cancer.
- Key Docs
- Official SEC press release